Medibank’s FY17 group NPAT of A$450 million was slightly ahead of consensus, largely on higher investment income with a 2H16 dividend of $0.0675 cents per share.
Based on FY18 EPS growth of 1 – 3%, we have MPL on a forward yield of 4.4%.
You're not a member! Trial today
